14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.98 $26.98 Thursday, 8th Jun 2023 MYOV stock ended at $26.98. During the day the stock fluctuated 0% from a day low at $26.98 to a day high of $26.98.
90 days $26.98 $26.98
52 weeks $9.81 $27.06

Historical Myovant Sciences Ltd prices

Date Open High Low Close Volume
Dec 21, 2016 $11.17 $11.17 $10.93 $11.01 39 567
Dec 20, 2016 $11.25 $11.27 $10.86 $11.03 119 029
Dec 19, 2016 $11.40 $11.45 $10.80 $11.19 82 381
Dec 16, 2016 $10.70 $11.71 $10.61 $11.51 968 440
Dec 15, 2016 $11.08 $11.50 $10.50 $10.80 96 836
Dec 14, 2016 $12.18 $12.35 $10.75 $11.08 109 938
Dec 13, 2016 $11.08 $12.01 $10.69 $11.79 186 421
Dec 12, 2016 $11.26 $11.33 $10.28 $11.00 110 980
Dec 09, 2016 $10.70 $11.51 $10.66 $11.29 106 014
Dec 08, 2016 $10.72 $11.00 $10.25 $10.70 58 358
Dec 07, 2016 $10.51 $10.90 $10.51 $10.59 63 954
Dec 06, 2016 $11.03 $11.09 $10.56 $10.70 132 552
Dec 05, 2016 $11.24 $11.89 $10.82 $10.95 108 251
Dec 02, 2016 $11.88 $12.10 $11.00 $11.35 140 214
Dec 01, 2016 $12.56 $12.80 $11.62 $11.91 106 627
Nov 30, 2016 $13.01 $13.15 $12.25 $12.60 122 826
Nov 29, 2016 $13.20 $13.20 $12.50 $12.86 118 652
Nov 28, 2016 $14.25 $14.25 $12.50 $12.90 192 179
Nov 25, 2016 $11.99 $14.27 $11.80 $14.25 289 297
Nov 23, 2016 $11.00 $12.23 $10.80 $11.91 500 708
Nov 22, 2016 $11.80 $11.80 $11.03 $11.03 124 264
Nov 21, 2016 $11.25 $11.81 $10.60 $11.21 341 428
Nov 18, 2016 $10.96 $11.46 $10.84 $11.25 110 571
Nov 17, 2016 $11.70 $11.84 $10.96 $11.00 27 419
Nov 16, 2016 $11.48 $11.95 $10.96 $11.93 151 709
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT